Compare WAL & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAL | BIO |
|---|---|---|
| Founded | 1994 | 1952 |
| Country | United States | United States |
| Employees | N/A | 7450 |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 9.7B |
| IPO Year | 2005 | 1994 |
| Metric | WAL | BIO |
|---|---|---|
| Price | $68.46 | $359.23 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 3 |
| Target Price | $89.50 | ★ $356.67 |
| AVG Volume (30 Days) | ★ 802.6K | 222.7K |
| Earning Date | 10-19-2026 | 11-04-2026 |
| Dividend Yield | ★ 2.64% | N/A |
| EPS Growth | 23.13 | ★ 142.61 |
| EPS | 6.43 | ★ 11.25 |
| Revenue | $135,800,000.00 | ★ $2,583,200,000.00 |
| Revenue This Year | $12.69 | N/A |
| Revenue Next Year | $4.25 | $1.86 |
| P/E Ratio | ★ $10.83 | $32.66 |
| Revenue Growth | ★ 99.71 | 0.65 |
| 52 Week Low | $65.82 | $236.73 |
| 52 Week High | $97.23 | $396.23 |
| Indicator | WAL | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 30.96 | 42.74 |
| Support Level | $65.82 | $350.89 |
| Resistance Level | $81.73 | $392.10 |
| Average True Range (ATR) | 2.23 | 12.70 |
| MACD | -0.85 | -1.98 |
| Stochastic Oscillator | 1.05 | 15.43 |
Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.